Prestige Consumer [PBH] vs Lantheus Holdings [LNTH] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Prestige Consumer Healthcare Inc. wins in 10 metrics, Lantheus Holdings Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Prestige Consumer Healthcare Inc. | Lantheus Holdings Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.18 | 24.30 | Prestige Consumer Healthcare Inc. |
| Price-to-Book Ratio | 1.49 | 4.91 | Prestige Consumer Healthcare Inc. |
| Debt-to-Equity Ratio | 59.00 | 57.19 | Lantheus Holdings Inc. |
| PEG Ratio | -0.75 | -0.04 | Lantheus Holdings Inc. |
| EV/EBITDA | 10.24 | 14.70 | Prestige Consumer Healthcare Inc. |
| Profit Margin (TTM) | 16.90% | 15.15% | Prestige Consumer Healthcare Inc. |
| Operating Margin (TTM) | 29.10% | 19.07% | Prestige Consumer Healthcare Inc. |
| EBITDA Margin (TTM) | 29.10% | 19.07% | Prestige Consumer Healthcare Inc. |
| Return on Equity | 10.31% | 21.45% | Lantheus Holdings Inc. |
| Return on Assets (TTM) | 6.13% | 9.28% | Lantheus Holdings Inc. |
| Free Cash Flow (TTM) | $243.29M | $348.64M | Lantheus Holdings Inc. |
| 1-Year Return | -44.52% | 31.42% | Lantheus Holdings Inc. |
| Price-to-Sales Ratio (TTM) | 2.51 | 3.50 | Prestige Consumer Healthcare Inc. |
| Enterprise Value | $3.74B | $5.62B | Lantheus Holdings Inc. |
| EV/Revenue Ratio | 3.39 | 3.65 | Prestige Consumer Healthcare Inc. |
| Gross Profit Margin (TTM) | 55.52% | 59.21% | Lantheus Holdings Inc. |
| Revenue per Share (TTM) | $23 | $23 | Lantheus Holdings Inc. |
| Earnings per Share (Diluted) | $3.79 | $3.41 | Prestige Consumer Healthcare Inc. |
| Beta (Stock Volatility) | 0.47 | -0.13 | Lantheus Holdings Inc. |
| Short % of Float | 8.04% | 10.95% | Prestige Consumer Healthcare Inc. |
Prestige Consumer Healthcare Inc. vs Lantheus Holdings Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -0.85% | -4.56% | -17.14% | -33.12% | -23.22% | -25.14% |
| Lantheus Holdings Inc. | 4.09% | -3.76% | 9.71% | 26.21% | 64.47% | 43.15% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -44.52% | -18.75% | -4.94% | -11.39% | 281.46% | 345.87% |
| Lantheus Holdings Inc. | 31.42% | 11.99% | 303.82% | 4,393.21% | 1,444.32% | 1,444.32% |
Performance & Financial Health Analysis: Prestige Consumer Healthcare Inc. vs Lantheus Holdings Inc.
| Metric | PBH | LNTH |
|---|---|---|
| Market Information | ||
| Market Cap | $2.78B | $5.39B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 403,677 | 641,334 |
| 90 Day Avg. Volume | 517,876 | 839,568 |
| Last Close | $45.44 | $100.24 |
| 52 Week Range | $42.62 - $87.12 | $47.25 - $103.89 |
| % from 52W High | -47.84% | -3.51% |
| All-Time High | $90.04 (Mar 10, 2025) | $126.89 (Jul 15, 2024) |
| % from All-Time High | -49.53% | -21.00% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.04% |
| Quarterly Earnings Growth | -0.24% | 0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.15% |
| Operating Margin (TTM) | 0.29% | 0.19% |
| Return on Equity (TTM) | 0.10% | 0.21% |
| Debt to Equity (MRQ) | 59.00 | 57.19 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $38.66 | $16.87 |
| Cash per Share (MRQ) | $1.32 | $5.56 |
| Operating Cash Flow (TTM) | $276.63M | $390.14M |
| Levered Free Cash Flow (TTM) | $207.17M | $265.57M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Prestige Consumer Healthcare Inc. vs Lantheus Holdings Inc.
| Metric | PBH (Apr 24, 2026) | LNTH (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.18 | 24.30 |
| Forward P/E | 11.96 | 13.17 |
| PEG Ratio | -0.75 | -0.04 |
| Price to Sales (TTM) | 2.51 | 3.50 |
| Price to Book (MRQ) | 1.49 | 4.91 |
| Market Capitalization | ||
| Market Capitalization | $2.78B | $5.39B |
| Enterprise Value | $3.74B | $5.62B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.39 | 3.65 |
| Enterprise to EBITDA | 10.24 | 14.70 |
| Risk & Other Metrics | ||
| Beta | 0.47 | -0.13 |
| Book Value per Share (MRQ) | $38.66 | $16.87 |
Financial Statements Comparison: Prestige Consumer Healthcare Inc. vs Lantheus Holdings Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PBH (2025) | LNTH (2025) |
|---|---|---|
| Revenue/Sales | 1.14B | 1.54B |
| Cost of Goods Sold | 503.30M | 599.66M |
| COGS % of Revenue | 44.2% | 38.9% |
| Gross Profit | 634.46M | 941.95M |
| Gross Margin | 55.8% | 61.1% |
| Research & Development | N/A | 177.31M |
| Operating Income (EBIT) | 349.24M | 315.56M |
| Operating Margin | 30.7% | 20.5% |
| EBITDA | 374.46M | 409.00M |
| EBITDA Margin | 32.9% | 26.5% |
| Pre-Tax Income | 284.19M | 313.79M |
| Pre-Tax Income % of Revenue | 25.0% | 20.4% |
| Income Tax | 69.58M | 80.23M |
| Income Tax % of Revenue | 6.1% | 5.2% |
| Net Income (Profit) | 214.61M | 233.56M |
| Profit Margin | 18.9% | 15.2% |
Balance Sheet & Liquidity Metrics
| Metric | PBH (2025) | LNTH (2025) |
|---|---|---|
| Cash & Equivalents | 97.88M | 359.12M |
| Total Current Assets | 448.33M | 899.96M |
| Total Current Assets % of Revenue | 39.4% | 58.4% |
| Total Current Liabilities | 106.62M | 333.42M |
| Total Current Liabilities % of Revenue | 9.4% | 21.6% |
| Long-Term Debt | 1.04B | 618.69M |
| Long-Term Debt % of Revenue | 91.0% | 40.1% |
| Total Shareholders Equity | 1.83B | 1.09B |
| Retained Earnings | 1.56B | 679.50M |
| Retained Earnings % of Revenue | 136.7% | 44.1% |
| Property, Plant & Equipment | 53.29M | 30.98M |
Cash Flow Statement Comparison
| Metric | PBH (2025) | LNTH (2025) |
|---|---|---|
| Operating Cash Flow | 227.18M | 398.13M |
| Operating Cash Flow % of Revenue | 20.0% | 25.8% |
| Capital Expenditures | -8.22M | N/A |
| Free Cash Flow | 243.29M | 348.64M |
| FCF Margin | 21.4% | 22.6% |
| Debt Repayment | -139.54M | -1.11M |
| Common Stock Repurchase | -51.51M | -300.02M |
Short Interest & Institutional Ownership Analysis
| Metric | PBH | LNTH |
|---|---|---|
| Shares Short | 2.69M | 5.36M |
| Short Ratio | 5.78 | 4.60 |
| Short % of Float | 8.04% | 10.95% |
| Shares Outstanding | 47.32M | 64.59M |
| Float Shares | 46.75M | 58.18M |
| % Held by Insiders | 1.30% | 2.04% |
| % Held by Institutions | 111.41% | 109.34% |
| % Held by Public | -12.71% | -11.38% |
Dividend Analysis & Yield Comparison: Prestige Consumer Healthcare Inc. vs Lantheus Holdings Inc.
| Metric | PBH | LNTH |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |